CHC Healthcare Group (TPE:4164) Accounts Payable: NT$449 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4164 CHC Healthcare Group TPE:4164
76 GF Score
Price NT$26.05
GF Value NT$52.32
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is CHC Healthcare Group Accounts Payable?

CHC Healthcare Group TPE:4164 +0.19% 76 Accounts Payable is NT$449 Mil as of Mar. 2026. GuruFocus rates TPE:4164 with a GF Score™ of 76/100 and a GF Value™ of NT$52.32 (Possible Value Trap). The stock has 8 warning signs investors should review.

CHC Healthcare Group's Accounts Payable for the quarter that ended in Mar. 2026 was NT$449 Mil.

CHC Healthcare Group's quarterly Accounts Payable increased from Sep. 2025 (NT$508 Mil) to Dec. 2025 (NT$519 Mil) but then declined from Dec. 2025 (NT$519 Mil) to Mar. 2026 (NT$449 Mil).

CHC Healthcare Group's annual Accounts Payable increased from Dec. 2023 (NT$376 Mil) to Dec. 2024 (NT$476 Mil) and increased from Dec. 2024 (NT$476 Mil) to Dec. 2025 (NT$519 Mil).

CHC Healthcare Group Accounts Payable Related Terms

CHC Healthcare Group Accounts Payable Historical Data

* Premium members only.

The historical data trend for CHC Healthcare Group's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CHC Healthcare Group Accounts Payable Chart

CHC Healthcare Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 199.51 325.73 375.89 475.57 518.54

CHC Healthcare Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 545.94 442.69 508.06 518.54 449.49
TPE:4164
76GF Score
CHC Healthcare Group TPE:4164
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CHC Healthcare Group Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$449 Mil mean?
CHC Healthcare Group (TPE:4164) has a Accounts Payable of NT$449 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on CHC Healthcare Group and its competitors.
Is CHC Healthcare Group's Accounts Payable too high?
CHC Healthcare Group's current Accounts Payable is NT$449 Mil. Overall, CHC Healthcare Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's Accounts Payable compare to MCK and COR?
CHC Healthcare Group's Accounts Payable of NT$449 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Distribution company?
A good Accounts Payable depends on the Medical Distribution industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on CHC Healthcare Group and its competitors. CHC Healthcare Group's current Accounts Payable is NT$449 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$52.32, compared to a current price of NT$26.05 — trading 50.2% below its estimated fair value. The current Accounts Payable is NT$449 Mil. CHC Healthcare Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current Accounts Payable is NT$449 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?

Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued. The current stock price of NT$26.05 is trading 50.2% below its estimated GF Value™ of NT$52.32. GuruFocus considers CHC Healthcare Group to be Possible Value Trap.

Key valuation signals for TPE:4164:

  • Accounts Payable: NT$449 Mil
  • GF Value™: NT$52.32 vs. price of NT$26.05 (50.2% below fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CHC Healthcare Group Business Description

Address No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
76GF Score

Get the complete analysis for TPE:4164

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.05
Price
NT$52.32
GF Value